Search This Blog

Friday, 31 August 2012

News of the 2013 EACPT Congress in Geneva

@HealthMed The EACPT's next biennial congress will be held in beautiful Geneva, 28th - 31st August in 2013 at the International Congress Centre of Geneva (CICG).
Registration will open 10th November 2012.
Abstract submissions will also open 10th November 2012 and will close 8th February 2013.
To receive updates on the congress before registering, you can submit your email address to the congress organisers.
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals and others interested in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.
Geneva by the lake
Key themes at the congress will range from bedside pharmacology for special patient groups to pharmacology & toxicology, and pharmacology and society. Specific topics will include sessions on communicating with the public, ethics, safe prescribing, clinical trial design and governance, and health policy; new biologicals, translational medicine and pharmacogenetics; advances in personalised diagnostics to improve the safety and effectiveness of medicines, updates on new biological approaches to ocular disease, therapeutics of cardiovascular, cancer and inflammatory disease, clinical trial design and regulation, and drug safety and toxicology. 
The European Association for Clinical Pharmacology and Therapeutics (EACPT) has its origins in a working party in the early 1980s under the auspices of the World Health Organisation (WHO-Europe). The EACPT's next biennial congresses after Geneva 2013 are in Madrid 2015 and in Prague 2017. The EACPT also arranges summer schools, and other scientific and professional activities.

For more on the Congress, how to contact the organisers, and how to register to receive updates, see:
Congress Website: http://www.eacpt2013.org
Secretariat email: eacptreg@mci-group.com

No comments:

Post a Comment